Mimivax

Disrupting cancer with innovative immunotherapies aimed at increasing patient survival rates

placeBuffalo, New York, United States calendar_todayFounded 2012 groups3 employees language mimivax.com

Social engagement

Social engagement: 976 social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Brain Tumor Investment Fund, The Sontag Foundation, Varia Ventures, MEDA Angels.

Investor typeCountShare
Venture capital457%
Accelerator & incubator114%
Other / undisclosed229%

Recent activity

30 Jan 2026
Event
Stand Up To Cancer Innovation Summit
Coming soon